DUBLIN, Dec. 13, 2023 /PRNewswire/ — The “Global Heparinoid Market – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The latest comprehensive research on the global heparinoid market, meticulously covering the period from 2023 to 2032, has been released and added to our expansive collection of market studies. This report encompasses a detailed… Continue reading Global Heparinoid Market Analysis and Forecast 2023-2032, Featuring Merck, TSI Group, Bioiberica and Kala Health
Category: Newswire
Green Airport Market to Reach $12.0 Billion, Globally, by 2032 at 10.2% CAGR: Allied Market Research
The growth of the global green airport is driven by factors such as stringent environmental regulations, increase in demand for operational cost savings and efficiency, and rise in awareness and concerns about environmental issues. WILMINGTON, Delaware, Dec. 13, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Green Airport Market by Energy Type (Wind Power,… Continue reading Green Airport Market to Reach $12.0 Billion, Globally, by 2032 at 10.2% CAGR: Allied Market Research
Keyshia Cole Headlines ‘Love Hard’ Tour With R&B Icon Trey Songz Featuring Jaheim, and K. Michelle
With Some of the Biggest R&B Stars, the Black Promoters Collective Promises the “Love Hard” Tour Will Be One For The Books THE GENERAL ON-SALE DATE IS FRIDAY, DECEMBER 15 PURCHASE TICKETS HERE NEW YORK, Dec. 13, 2023 /PRNewswire/ — Get ready for an unforgettable experience as the “Love Hard” tour prepares to take center… Continue reading Keyshia Cole Headlines ‘Love Hard’ Tour With R&B Icon Trey Songz Featuring Jaheim, and K. Michelle
Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
DUBLIN, Dec. 13, 2023 /PRNewswire/ — The “Cancer Immunotherapy Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to ResearchAndMarkets.com’s offering. Industry analysts have unveiled a comprehensive study unveiling that the global cancer immunotherapy market is projected to reach an estimated value of over US$ 188.11… Continue reading Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $9.2 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Increase in incidence of stroke, innovations in treatment options, and advancements in imaging technologies drive the growth of the global acute ischemic stroke diagnosis and treatment market. PORTLAND, Ore., Dec. 13, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Acute Ischemic Stroke Diagnosis and Treatment Market by Type (Diagnostics and Treatment), and End User, (Hospitals… Continue reading Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $9.2 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Asia-Pacific Sustainable Steel Industry 2022-2031: Focus on the Impacts of Strict government Regulations and Carbon Neutrality Objectives
DUBLIN, Dec. 13, 2023 /PRNewswire/ — The “Asia-Pacific Sustainable Steel Market – Analysis and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering. The Asia-Pacific sustainable steel market (excluding China) is projected to reach $153.4 billion by 2031 from $68.4 billion in 2022, growing at a CAGR of 9.39% during the forecast period 2022-2031. Leading the way… Continue reading Asia-Pacific Sustainable Steel Industry 2022-2031: Focus on the Impacts of Strict government Regulations and Carbon Neutrality Objectives
FONTAINEBLEAU LAS VEGAS CELEBRATES GLOBALLY AWAITED GRAND OPENING WITH CEREMONIAL RIBBON CUTTING CEREMONY
Key to the Strip, congressional proclamations presented as December 13 is declared ‘Fontainebleau Las Vegas Day’ on the Strip Link to images courtesy Getty Images for Fontainebleau Las Vegas LAS VEGAS, Dec. 13, 2023 /PRNewswire/ — In a prelude to one of Las Vegas’ most anticipated grand openings, Fontainebleau Las Vegas hosted a ribbon cutting ceremony on Wednesday,… Continue reading FONTAINEBLEAU LAS VEGAS CELEBRATES GLOBALLY AWAITED GRAND OPENING WITH CEREMONIAL RIBBON CUTTING CEREMONY
Immutable Announces Industry-First zkEVM Blockchain With a Gas-Free Player Experience
Immutable’s new gaming blockchain eliminates the primary point of user friction, empowering developers to offer familiar gaming experiences to their communities SYDNEY, Dec. 13, 2023 /PRNewswire/ — Leading gaming company Immutable today announces that Immutable zkEVM — a next-gen Zero-Knowledge (ZK) proof-based scaling platform developed in collaboration with Polygon Labs — will allow developers to… Continue reading Immutable Announces Industry-First zkEVM Blockchain With a Gas-Free Player Experience
Check Cashing Services Market to Reach $ 65.8 Billion, Globally, by 2032 at 9.4% CAGR: Allied Market Research
Surge in the adoption of digital technologies, increase in focus on regulatory compliance, and high speed of transactions contribute toward the growth of the market PORTLAND, Ore. , Dec. 13, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Check Cashing Services Market by Service Provider (Banks, Credit Unions, and Others), Type (Pre-Printed Checks, Payroll Checks, Government… Continue reading Check Cashing Services Market to Reach $ 65.8 Billion, Globally, by 2032 at 9.4% CAGR: Allied Market Research
Abbisko Therapeutics Announces that U.S. FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021)
SHANGHAI, Dec. 13, 2023 /PRNewswire/ — Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics”) today announced that its CSF-1R inhibitor pimicotinib (ABSK021) has been granted the fast track designation (“FTD”) by the U.S. FDA for the treatment of tenosynovial giant cell tumor (“TGCT”) patients that are not amenable to surgery. Previously, pimicotinib was granted the breakthrough therapy designation (“BTD”)… Continue reading Abbisko Therapeutics Announces that U.S. FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021)